L2 Asset Management, LLC Pfizer Inc Transaction History

L2 Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$32.09 - $37.51 $731,780 - $855,378	-22,804 Reduced 95.4%	1,099 $36,000
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $88,277 - $102,134	-2,444 Reduced 9.28%	23,903 $876,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $73,422 - $95,585	-1,864 Reduced 6.61%	26,347 $1.07 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $273,806 - $334,248	6,257 Added 28.5%	28,211 $1.24 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $434,450 - $515,122	9,337 Added 74.0%	21,954 $1.15 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $421,357 - $522,114	9,210 Added 270.33%	12,617 $653,000
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $140,777 - $208,678	3,407 New	3,407 $201,000
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $253,309 - $307,301	-8,410 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $416,802 - $595,520	-15,420 Reduced 64.71%	8,410 $275,000
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $784,483 - $890,288	23,830 New	23,830 $934,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of L2 Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on L2 Asset Management, LLC with notifications on news.